Sage therapeutics stock price target
Get breaking news and analysis on Sage Therapeutics, Inc. (SAGE) stock, price quote and chart, trading and investing tools. SAGE THERAPEUTICS, INC. : SAGE Stock Price | MarketScreener SAGE Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing and commercializing medicines to treat central nervous system (CNS) disorders. The Company's lead product candidate, SAGE-547 is an intravenous formulation of allopregnanolone, a … Sage Therapeutics: A Promising CNS Play In July 2019 ... Jul 08, 2019 · Sage Therapeutics has undoubtedly been one of the top-favorite biotech plays in fiscal 2019.The stock is up by a whopping 88.40% in 2019 YTD. The biggest share price hike for the
Analysts Have Conflicting Sentiments on These Healthcare ...
SAGE Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing and commercializing medicines to treat central nervous system (CNS) disorders. The Company's lead product candidate, SAGE-547 is an intravenous formulation of allopregnanolone, a … Sage Therapeutics: A Promising CNS Play In July 2019 ... Jul 08, 2019 · Sage Therapeutics has undoubtedly been one of the top-favorite biotech plays in fiscal 2019.The stock is up by a whopping 88.40% in 2019 YTD. The biggest share price hike for the SunTrust Banks Lowers SAGE Therapeutics (NASDAQ:SAGE ...
Mar 27, 2020 · Stock quote for Sage Therapeutics, Inc. Common Stock Common Stock (SAGE) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq.
SAGE's NASDAQ Last Sale (NLS) "Last Sale" is the price at which a stock last traded during regular market hours. NLS Volume "Volume" is the number of shares of the stock traded on the listing exchange during regular trading hours. Previous Close Today's High / Low 52 Week High / Low SAGE THERAPEUTICS, INC. : Target Price Consensus and ...
SAGE Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing and commercializing medicines to treat central nervous system (CNS) disorders. The Company's lead product candidate, SAGE-547 is an intravenous formulation of allopregnanolone, a …
Apr 03, 2020 · Real-time trade and investing ideas on Sage Therapeutics SAGE from the largest community of traders and investors. Market Data by Xignite and BATS BZX Real-Time Price. Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC. SAGE Therapeutics Inc : SAGE Stock Price Quote at Ally Invest Analyst Actions: Citigroup Starts Sage Therapeutics at Buy With $71 Price Target 8:35AM ET 3/06/2020 MT Newswires. Sage Therapeutics (SAGE) has an average …
20 Wall Street analysts have issued twelve-month price objectives for SAGE Therapeutics' shares. Their forecasts range from $28.00 to $263.00. On average, they expect SAGE Therapeutics' stock price to reach $100.05 in the next twelve months. This suggests a possible upside of 285.1% from the stock…
See SAGE Therapeutics price target based on 14 analysts offering 12 month price targets for SAGE Therapeutics in the last 3 months. The average price target is $68.00 with a high forecast of $98.00 and a low forecast of $28.00. The average price target represents a … Sage Therapeutics, Inc. Common Stock (SAGE) Analyst ... Mar 20, 2020 · Find the latest analyst research for Sage Therapeutics, Inc. Common Stock (SAGE) Based on analysts offering 12 month price targets for SAGE … Sage Therapeutics, Inc. - SAGE - Stock Price Today - Zacks First Week of May 8th Options Trading For Sage Therapeutics (SAGE) 03/31/20-9:43AM EST Stock Options Channel Sage Therapeutics price target lowered … SAGE Therapeutics (NASDAQ:SAGE) Price Target Cut to $117 ...
3 Mar 2020 The Healthcare company has also assigned a $78 price target. H.C. Wainwright wasn't the only research firm that published a report of Sage